b-defensins are small, cationic peptides with broad-spectrum antimicrobial activity that are produced by mucosal epithelia. However, little is known about the expression of b-defensins in the major salivary glands. The purpose of this study was to characterize expression of rat b-defensin-1 (RBD-1) and -2 (RBD-2) mRNA within the major salivary glands together with the effect of injection of intraductal lipopolysaccharide (LPS) on that expression. b-defensin mRNA expression was quantitated by RT-PCR in salivary gland tissues and salivary acinar and striated duct cells collected by laser captured microdissection. RBD-1 and -2 were expressed in the parotid gland, the submandibular gland, and the sublingual gland. b-defensins were expressed in both the acinar and striated duct cells of the major salivary glands. Intraductal injection of LPS increased expression of RBD-1 and -2 mRNA, which peaked at 12 hrs. These results suggest that salivary cells (acinar and striated duct cells) have the potential to produce b-defensins.
Introduction
Defensins are cationic peptides with broadspectrum antimicrobial activity that are produced by mucosal epithelia. Defensins are grouped into two subfamilies, referred to as a-and b-defensins. The a-defensins are produced in remarkably large amounts (5-10 mg/ kg body weight/day) in human bone marrow during maturation of polymorphonuclear leukocytes 15) , while the a-defensins are released by neutrophils into the gingival crevicular 14) . Recent research has provided evidence of the existence of b-defensins in the brain 7) , tongue, esophagus, trachea 8) , intestinal epithelial cells 1, 3, 6) , pancreas 14) , neutrophils 10) , gingiva 2) , saliva, and salivary glands [3] [4] [5] [11] [12] [13] 19) . It was reported that expression of human b-defensin-1 (HBD-1) was constitutive, while that of human b-defensin-2 (HBD-2) in human was induced in the salivary glands by Interleukin-1b (IL-1b) and lipopolysaccharide (LPS) 11) . However, expression of rat b-defensin-1 (RBD-1) and -3 (RBD-3) increased in rat parotid gland (PG) at 3 hrs and 6 hrs after injection of LPS, whereas that of rat b-defensin-1 (RBD-1) was unaffected 4) . In rat salivary glands, b-defensins are present in the PG, but not in the submandibular glands (SMG) or sublingual glands (SLG) 4) . However, whether intraductal injection of LPS increases expression of b-defensin in the acinar or striated duct cells is unclear. Saliva is produced in acinar cells and released into the lumen via striated duct cells, thereby participating in the protection of the oral structures from microbes. The purpose of this study was to investigate expression of RBD-1 and -2 in rat PG, SMG, and SLG both before and after intraductal injection of LPS.
Materials and Methods

Animals and experimental design
Male Wistar rats weighing 200±3 g (mean±S.E.M.) each were purchased from Japan SLC, Inc. (Hamamatsu, Japan) and given water and food ad libitum. All animal experiments were performed according to the Guidelines for the Treatment of Experimental Animals at Tokyo Dental College (Admission no: 180701). The parotid duct was exposed through the skin and a fine polyethylene tube filled with LPS and attached to a syringe inserted in the direction of the glands under anesthesia with pentobarbital sodium (50 mg/kg, i.p., Somnopentyl, Kyoritsu Shoji, Tokyo, Japan). Fifty microliters of LPS (0.05 mg/ml in saline, 2 mM) purified from E. coli O111:B4 (Molecular Weight 415) (Sigma-Aldrich, St. Louis, MO, USA) was injected towards the gland for 1 min. After injection, the tube was closed by heating and left in place for 1 hr. Control animals received saline vehicle (50 ml) without LPS, while naïve rats received no saline. After intraductal injection of LPS, the rats were sacrificed by cardiac puncture under anesthesia. The major salivary glands were then dissected free of fat, connective tissue, and lymph nodes, and collected.
Laser Capture Microdissection (LCM)
The Zeiss P.A.L.M. laser microdissection system (Carl Zeiss Microscopy, Jena, Germany) was used for the microdissection and capture of cells. Frozen tissue samples were cut into 7-mm thick sections and mounted onto PALM MembraneSlides (Carl Zeiss Microscopy). The sections were air-dried at room temperature for 30 sec and then fixed in ice cold 100% methanol for 1 min, after which they were stained with 0.1% toluidine blue for 1 min and rinsed in Diethylpyrocarbonate (DEPC)-treated water for another 1 min. Dehydration of the sections was performed by treatment with 100% ethanol for 30 sec. The sections were air-dried, stored on ice, and microdissected on the same day. After Laser Pressure Catapulting into adhesive caps (Fig. 1 ) using the PALM MicroLaser system (Carl Zeiss Microscopy), approximately 1,000 acinar or striated duct cells were obtained per tissue (PG, SMG, and SLG) from 5 rats each at 12 hrs after intraductal injection of saline and LPS.
RNA extraction
Total RNA from the acinar and striated duct cells was extracted using the RNeasy Qiagen Minikit (Qiagen, Hilden, Germany). Total RNA from rat PG, SMG, and SLG tissues was extracted using NucleoSpin RNA (Machery-Nagel, Düren, Germany). After treatment with DNaseI, first-strand cDNA was synthesized using Oligo (dT) [12] [13] [14] [15] [16] [17] [18] 
Absolute quantitative RT-PCR
Gene expression of RBD-1 and -2 was determined by RT-PCR using the rat glyceraldehyde-3-phosphate dehydrogenase (RGAPDH; accession number NM_017008) gene as an internal control and primers specific for RBD-1 mRNA (accession number NM_031810) and -2 mRNA (accession number NM_022544). Primers were purchased from Takara Bio Inc. (Ootsu, Japan). The forward primer sequences were TCT CTG CAC TCT GGA CCC TGA C (RBD-1), TGG AGG CAT CGG TAT TGA TCT G (RBD-2) and GGC ACA GTC AAG GCT GAG AAT G (RGAPDH); the reverse primer sequences were TGG AGG CAT CGG TAT TGA TCT G (RBD-1), CAG TCC ACA AGT GCC AAT CTG TC (RBD-2), and ATG GTG GTG AAG ACG CCA GTA (GAPDH). Product sizes of 147 base pairs (bp) were observed for RBD-1, 181 bp for RBD-2, and 143 bp for RGAPDH. The cDNA was amplified by RT-PCR using the DyNAmo SYBR green qPCR Kit (Thermo Fisher Scientific, Waltham, MA, USA) on the DNA Engine Opticon™ 3 System (Bio-Rad Laboratories, Hercules, CA, USA) running 40 cycles of the following protocol: 15 min predenaturation at 95°C, 10 sec denaturation at 95°C, 20 sec annealing at 60°C for RBD-1, -2, and GAPDH, followed by a 30-sec extension at 72°C. Ten-fold serial dilutions of the cDNA were used to construct a standard curve from 10 6 to 10 1 copies, similarly to the method of Yoshikawa et al. 18) . Water samples treated with DEPC were reverse transcribed and amplified in parallel as a negative controls, and mRNA from PG, SMG, and SLG was used as a positive control. RT-PCR of rat salivary gland cDNA with primers for RBD-1, -2, and GAPDH produced a single product of the expected size as determined by the Agilent 2100 Bioanalyzer. Melting curve analyses revealed that the RBD-1-and -2-specific primer pairs amplified a single predominant product with a melting temperature of 85.0°C (RBD-1, RGAPDH) and 85.5°C (RBD-2). The temperature at which the rate of change of fluorescence (−d Intensity /d Temperature ) is the greatest is defined as the melting temperature for the product. Melting curve analyses of the PCR products amplified from the cDNAs confirmed the specificity of the reaction as a single peak. Furthermore, identification of the amplified PCR products of RBD-1, -2, and RGAPDH cDNAs was performed by dye terminator cycle sequencing.
Preparation for riboprobes for in situ hybridization
PCR primers specific for RBD-1 and -2 were used for in situ hybridization (ISH). In the case of the antisense probe for ISH, PCR was performed with the forward primer (TCT CTG CAC TCT GGA CCC TGA C) and the reverse primer linked with T7 RNA polymerase promotor at the 5' ends (CTT AAT ACG ACT CAC TAT AGG GTG GAG GCA TCG GTA TTG ATC TG). The PCR mix con- tained cDNA from an equivalent of 50 ng RNA, 0.5 mM of the appropriate primers, and 1×PCR Master Mix (Promega, Tokyo). The PCR program involved an initial denaturing at 94°C for 30 sec, annealing at 55°C for 30 sec, and extension at 72°C for 1 min, followed by extension at 72°C for 7 min. Fifty nanograms of the PCR product were added to an in vitro transcription reaction containing final concentrations of 1 mM CTP, ATP, and GTP, 0.65 mM UTP, 0.35 mM DIG-UTP (DIG RNA Labeling Mix; Roche Diagnostics, Tokyo), 80 units of T7 RNA polymerase (Roche Diagnostics), and 80 units of RNase inhibitor (Roche Diagnostics). The reaction volume was brought up to 20 ml per sample and incubated for 2 hrs at 37°C. The probe yield was determined by comparing serial dilutions of the probe to DIG-labeled Control RNA (Roche Diagnostics).
In situ hybridization
Nonradioactive ISH based on TSA was performed according to the method described by Yang et al. 16) with several modifications. Deparaffinized sections were digested with 5mg/ml proteinase K (Roche Diagnostics) at 37°C, post-fixed in 4% PFA, treated with 0.1 N HCl, and acetylated with 0.25% acetic anhydride in 0.1 M triethanol amine (pH 8.0) for 10 min each. After treatment with 3% hydrogen peroxidase for 1 hr, the sections were dehydrated and air-dried. Fifty microliters of a hybridization mixture (mRNA In situ Hybridization Solution; DakoCytomation Co., Ltd., Kyoto) containing 50 ng cRNA probe was used and hybridized with the sections for 16-18 hrs at 50°C. After hybridization, the sections were immersed briefly in 5×SSC (1×SSC: 0.15 M NaCl and 0.015 M sodium citrate) and then washed in 50% formaldehyde/2×SSC for 30 min at 55°C. After rinsing in 1×TNE (10 mM Tris-HCl, pH 7.6, 1 mM EDTA, 0.5 M NaCl) for 10 min at 37°C, the sections were treated with 10 mg/ml RNase A (Roche Diagnostics) for 30 min at 37°C; after rinsing in 1×TNE for 10 min at 37°C, they were then stringently washed sequentially in 2×SSC, 0.2×SSC, and 0.1×SSC for 20 min each at 55°C; and after rinsing in TBS(2)-T (0.01 M Tris-HCl, pH 7.5, 300 mM NaCl, 0.5% Tween-20) 3 times for 5 min, and in 0.5% casein/TBS (0.01M Tris-HCl, pH 7.5, 150 mM NaCl) for 10 min, they were reacted with a 1:400 diluted horseradish peroxidase (HRP)-conjugated rabbit anti-DIG F (ab') fragment antibody (DakoCytomation), 0.7 mM biotinylated tyramide solution, and 1:500 diluted HRP-conjugated streptavidin (DakoCytomation) for 15 min each at room temperature. Finally, color was developed using the DAB Liquid System (DakoCytomation) and counterstaining performed with Mayer's Hematoxylin.
Statistics
The results are given as the mean and standard error of the mean (S.E.M.) of the data. A statistical analysis was conducted using computer software (Prism, version 5.0c, GraphPad Software, San Diego, CA, USA) for a comparison across the experimental conditions. The Mann-Whitney U test was used for a statistical evaluation of mRNA levels in rat salivary glands at 12 hrs after intraductal injection of saline or LPS. When a significant difference between saline-and LPS-treated groups was obtained in a two-way (drugs and time) repeated measures analysis of variance (ANOVA) covering the 24-hr period following intraductal injection of saline or LPS, the Bonferroni test was applied to determine significance at each time point. Level of statistical significance was set at p<0.05 and p<0.01.
Results
Expression of RBD-1 and -2 mRNA in rat salivary gland tissues after intraductal LPS injection
To clarify change in expression of RBD-1 and -2 in salivary gland tissues with exposure to LPS, the rats were intraductally injected with LPS. Figures 2a, b , and c show timedependent changes in the levels of RBD-1 mRNA in PG, SMG, and SLG (Fig. 2c), respectively, while Figs. 2d, e, and f show the same in levels of RBD-2 mRNA in PG, SMG, and SLG, respectively, after unilateral intraductal injection of LPS (50 ml, 0.05 mg/ml) according to the results of RT-PCR analyses. The levels of RBD-1 and -2 mRNA were highest in PG. Levels of RBD-1 mRNA in SMG and SLG were approximately 32.2 and 17.3% of that in PG, respectively. The level of RBD-2 mRNA expression in SMG and SLG was approximately 8.1 and 6.4% of that in PG, respectively. Following intraductal injection of LPS, the level of RBD-1 mRNA in PG, SMG, and SLG significantly increased, peaking at 12 hrs. At 12 hrs after intraductal injection of LPS, the level of RBD-1 increased 12.6-, 4.7-, and 4.0-fold, and the level of RBD-2 increased by 9.0-, 11.4-, and 7.7-fold compared with that in the saline-treated group in PG, SMG, and SLG, respectively.
Expression of RBD mRNA in acinar and striated duct cells in rat salivary glands after intraductal LPS injection
Since salivary glands contain both acinar and striated duct cells, change in expression of RBD-1 and -2 with application of LPS was also compared between these two types of cell. Rat acinar and striated duct cells with or without LPS treatment were collected from the salivary tissues by LCM and subjected to RT-PCR analyses for quantification of change in expression of RBD-1 and -2 mRNA (Fig. 3) . RBD-1 and -2 mRNA was detected in both striated duct and acinar cells in PG, SMG, and SLG. The expression levels of RBD-1 and -2 mRNA in PG were higher than those in SMG or SLG. Whereas expression of RBD-1 showed only a slight increase in acinar cells after injection of LPS, this increase was significant in striated duct cells in PG, SMG, and Fig. 4a) or RBD-2 (Fig. 4d) . Positive signals were obtained in the acinar and intercalated ducts with the antisense probes for RBD-1 (Fig. 4b ) and RBD-2 ( Fig.  4e) , whereas no signals were detected with the sense probes for RBD-1 (Fig. 4c) or RBD-2 ( Fig. 4f) in the LPS-treated group.
Discussion
The results of this study showed that exposure to LPS, a bacterial endotoxin, induced inflammation in salivary glands (PG, SMG, and SLG), with acinar and striated duct cells in those glands transiently producing RBD-1 and -2. Both RBD-1 and -2 increased in all three types of gland after intraductal injection of LPS compared with in the saline-treated group. Expression of RBD-1 and -2 in the salivary glands did not differ between salinetreated and naïve rats (data not shown). These results indicate that the observed increase in expression of RBD-1 and -2 was not caused by the pressure of the intraductal injection, but by the injected LPS. Gene expression of RBD-1 and -2 was constitutively higher in striated duct than in acinar cells, while expression of both genes showed a marked increase by injection with LPS in the salivary cells of the major salivary glands. Expression of BD was reported to increase in ulcerative colitis 6) , gingivitis 2) , and inflammation of rat PG 4) . Expression of RBD-1 and -3 protein was demonstrated to be induced in inflamed PG by using an ELISA assay, but not in SMG or SLG 4) . In the present study, RBD-1 and -2 mRNA were detected in PG, SMG, and SLG using quantitative RT-PCR, which is extremely precise. RBD-1 and -2 were found to be abundantly expressed in PG, and their expression levels were highest at 12 hrs after intraductal injection of LPS. A previous study showed that expression of RBD-1 and -3 was still elevated at 6 hrs after intraductal injection of LPS 4) . In human umbilical vein endothelial cells, IL-6 and -8 levels showed a steady increase from 4 to 24 hrs after LPS stimulation 9) . The mRNA level of IL-1-b, IL-6, and tumor necrosis factor-a (TNF-a) in mouse SMG was reported to start increasing as early as 3 hrs after intraperitoneal injection of LPS, peaking at 3-6 hrs, and then decreasing again by 24 hrs 17) . Human major salivary gland cells constitutively express the bacterial pattern recognition receptor CD14 16) . Furthermore, inflammatory cytokines (i.e. IL-1b, IL-6 and TNF-a) were reported to be induced by LPS stimulation via Toll-like receptor-4 (TLR-4) in mouse SMG 17) . Increased expression of RBD-1 and -2 mRNA in salivary glands by exposure to LPS may contribute to anti-inflammatory activities, and was observed in both acinar and striated duct cells in this study. It is believed that RBDs are released into the lumen of the salivary glands, where they become a component of saliva and play an important role in protecting the body from infection. The existence of both RBD-1 and -2 within isolated salivary cells has been controversial. The present findings, however, clearly indicate quantitative differences in RBD-1 and -2 mRNA in both the steady and LPS-inducible state in both acinar and striated duct cells isolated by LCM. These results suggest that acinar and striated duct cells produce RBD-1 and -2, and that this expression is involved in prevention of bacterial invasion. RBD-1 and -2 may be released into the lumen where they become constituents of the saliva, thereby participating in the protection of the oral structures. Furthermore, RBD-1 and-2 located in the ducts may prevent microbes from entering the parenchyma. Striated duct cells are exposed to the oral cavity, and are therefore easily infected by microorganisms. In this study, expression of RBD-1 and -2 mRNA in striated duct cells was higher than that in acinar cells after injection of LPS. This indicates that RBD-1 and -2 play an important role in protecting acinar and especially striated duct cells. The mechanisms by which microorganisms are killed by defensins are not yet completely understood. Innate immunity is triggered immediately after microbial invasion in response to highly conserved structures present in large groups of microorganisms (e.g. LPS) 17) . Further research should investigate expression levels of RBD-1 and -2 mRNA in cells as well expression levels of RBD-1 and -2 protein in saliva to clarify the relationship between RBD-1 and -2 synthesis in salivary gland cells and RBD-1 and -2 secretion.
